Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

about

Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

Item

http://www.wikidata.org/entity/Q39004220

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

@en

Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

@nl

type

Item

label

Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

@en

Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

@nl

prefLabel

Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

@en

Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

@nl

P1476

Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

@en

P2093

Anthony A Bavry

http://www.w3.org/2001/XMLSchema#string

Asghar Ali

http://www.w3.org/2001/XMLSchema#string

Calvin Choi

http://www.w3.org/2001/XMLSchema#string

Douglas M Heuman

http://www.w3.org/2001/XMLSchema#string

Ion S Jovin

http://www.w3.org/2001/XMLSchema#string

Michael Fuchs

http://www.w3.org/2001/XMLSchema#string

Robert J Donovan

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization

Risk prediction models for contrast induced nephropathy: systematic review

Echocardiography in liver transplant candidates

Fractional flow reserve versus angiography for guiding percutaneous coronary intervention

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Coagulation in liver disease: a guide for the clinician.

Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation.

Cardiac catheterization in patients with end-stage liver disease: safety and outcomes.

Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

P2888

s10620-016-4371-3

P304

26-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-016-4371-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27830409

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation